Michael Fradley
Medical Director, Cardio-Oncology Program · Perelman School of Medicine at the University of Pennsylvania
Credentials: · · · · · ·
History
- Present
Cardio-Oncology Program · Perelman School of Medicine at the University of Pennsylvania
- Present
Perelman School of Medicine at the University of Pennsylvania · University of Pennsylvania Health System
- 2011–2013
Clinical Cardiac Electrophysiology
- 2008–2011
- 2005–2008
- 2001–2005
Research
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
Journal of the American College of Cardiology · 2018 · 1,305 citations
Annals of Oncology · 2020 · 761 citations
European Journal of Heart Failure · 2020 · 646 citations
31 papers
23 papers
22 papers
- DL
21 papers
- PT
19 papers
18 papers
17 papers
16 papers
Clinical trials
- 2024–2026
Hypertension and Arrhythmias in CLL Patients Treated With BTK Inhibitors
Principal investigator · Enrolling by invitation
Abramson Cancer Center at Penn Medicine
- 2021–2024
Long Term Arrhythmia Risk and Cardiovascular Events in Hematopoietic Stem Cell Transplant
Principal investigator · Completed
Abramson Cancer Center at Penn Medicine
- 2015–2019
Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation
Principal investigator · Completed · Phase 3
University of South Florida
- 2022–2029
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Site PI · Recruiting · Phase 3
Massachusetts General Hospital